Oral theophylline for chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

Oral theophylline for chronic obstructive pulmonary disease

Published:2002-10-21 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Ram Felix SF¹,Jones Paul²,Jardim Jose³,Castro Aldemar A⁴,Atallah Álvaro N⁵,Lacasse Yves⁶,Goldstein Roger⁷,Cendon Sonia³

Affiliation:

1. Massey University - Auckland; School of Health Sciences; 24 Portsea Place Chatswood, North Shore Auckland New Zealand

2. St George's Hospital Medical School; Cardiovascular Medicine; Cranmer Terrace London UK SW17 0RE

3. Escola Paulista de Medicina, Universidade Federal de São Paulo; Disciplina de Pneumologia; Rua Botucatu 740 - 3o. andar São Paulo São Paulo Brazil 04023-062

4. State University of Heath Science; Department of Public Health; 113, Jorge de Lima Street Trapiche Maceió Alagoas Brazil 57010382

5. Centro de Estudos de Medicina Baseada em Evidências e Avaliação Tecnológica em Saúde; Brazilian Cochrane Centre; R. Borges Lagoa, 564 cj 63 Vila Clementino São Paulo São Paulo Brazil 04038000

6. Institut Universitaire de Cardiologie et de Pneumologie de Québec, Hôpital Laval; 2725 Chemin Sainte-Foy Québec Quebec Canada G1V 4G5

7. West Park Healthcare Centre, University of Toronto; Division of Respiratory Medicine; 82 Buttonwood Avenue Toronto Ontario Canada M6M 2J5

Publisher

Wiley

Subject

Pharmacology (medical)

Reference141 articles.

1. Treatment of chronic obstructive pulmonary disease with orally administered theophylline;Alexander;The Journal of the American Medical Association,1980

2. The efficacy of isoproterenol inhalation for predicting the response to orally administered theophylline in chronic obstructive pulmonary disease;Dull;American Review of Respiratory Disease,1982

3. Sustained-release theophylline in chronic bronchitis;Anderson;British Journal of Diseases of the Chest,1982

4. Dose response relation to oral theophylline in severe chronic obstructive airways disease;Chrystyn;British Medical Journal,1988

5. Efficacy of inhaled metaproterenol and orally-administered theophylline in patients with chronic airflow obstruction;Dullinger;Chest,1986

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How Does the Powder Mixture of Ibuprofen and Caffeine Attenuate the Solubility of Ibuprofen? Comparative Study for the Xanthine Derivatives to Recognize Their Intermolecular Interactions Using Fourier-Transform Infrared (FTIR) Spectra, Differential Scanning Calorimetry (DSC), and X-ray Powder Diffractometry (XRPD);Molecular Pharmaceutics;2024-08-07

2. Management of Refractory Chronic Obstructive Pulmonary Disease: A Review;Life;2024-04-24

3. All shook up: how the COVID-19 pandemic rocked pediatric asthma care;Current Opinion in Pediatrics;2024-01-22

4. Effects of doxofylline as an adjuvant on severe exacerbation and long‐term prognosis for COPD with different clinical subtypes;The Clinical Respiratory Journal;2023-08-10

5. Patterns and Trends in the Use of Medications for COPD Control in a Cohort of 9476 Colombian Patients, 2017–2019;International Journal of Chronic Obstructive Pulmonary Disease;2023-07